| 标题 |
Four-year survival outcomes with dostarlimab plus chemotherapy in dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gynecologic Oncology 作者:Matthew Powell; Oleksandr Zub; Lucy Gilbert; Anthoula Koliadi; Lyndsay Willmott; et al 出版日期:2026-04-23 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)